An interventional study of Static and dynamic perineo-pelvic MRI in Transgenderism, sponsored by University Hospital, Limoges. Recruiting at 1 site in France. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-22.
Sponsored by University Hospital, Limoges · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.
Transgender people are estimated to be about 0,3 to 1 % of general population, and MtF reassignment surgery is raising. Vaginoplasty is not always necessary, but is usually an important step into gender transition. In France, surgical techniques' gold-standard is the peno-scrotal inversion vaginoplasty, which consists in the creation of a neo-vagina with peno-scrotal skin graft. Genital, perineum and pelvic anatomy is modified, without knowing in advance about functional and aesthetic results. MRI is the best way to assess soft tissue anatomy in the pelvis. Though, only few studies have assessed pre and post-operative imaging in patients undergoing vaginoplasty, and none have been prospective, neither have assessed the risk of rectocele. The issue is legitimate, because the surgery weakens elements of pelvic fixity, and fixity issues can appear secondarily.
MtF transgender patients operated for a vaginoplasty are undergoing static and dynamic MRI before the surgery, at 6 and at 24 post-operative months. We look after the appearance of a rectocele and it's evolution in time, as criteria for the assessment of pelvic fixity.
Follow-up is composed of several consultations including post-operative MRI, but also clinical measures, census of post-operative issues, and questionnaires for the assessment of secondary objectives.
54 studies on the registry are indexed under Transsexualism; 18 are open to participants now.
This study's planned enrollment of 50 is above the median of 44 across 26 interventional studies indexed under Transsexualism.
Browse Transsexualism studies →University Hospital, Limoges is the lead sponsor of 265 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.
Diagnostic Test: Static and dynamic perineo-pelvic MRI
Static and dynamic perineo-pelvic MRI before surgery, and at 6 and 24 months after surgery.
Measurement comparison of the rectal bulge's size and classification
Comparison and classification by pre-operative and post-operative MRI
Time frame: 6 months and 24 months
Rectocele
Describe the rectocele's mean size and it's progress
Time frame: 6 months and 24 months
Rectocele
Describe the rectocele size's progress by class
Time frame: 6 months and 24 months
Reproducibility in the rectocele's measurement
Evaluate intra and inter-operator reproducibility in the rectocele's measurement
Time frame: 6 months and 24 months
Symptomatology pelvic fixity
Evaluate correlation between symptomatology and the rectocele assessment
Time frame: 6 months and 24 months
Factors pelvic fixity
Evaluate correlation between factors and the rectocele assessment
Time frame: 6 months and 24 months
Skin-graft's neo-vagina's sizes
Evaluate correlation between the skin-graft's size in cm² and the neo-vagina's sizes (lenght, width) in cm
Time frame: 6 months and 24 months
Imaging measures
Evaluate modifications of imaging measures size in cm² and the neo-vagina's sizes (lenght, width) in cm
Time frame: 6 months and 24 months
Urinary quality
Evaluate evolution of unrinary quality of life with Urinary Symptom Profile (USP) score, from 0 (best) to 39 (worst)
Time frame: 6 months and 24 months
Self-imaging
Evaluate evolution of self-imaging with Body Image (BI-1) score, from 30 (no change) to 150 (change) ; and Female Genital Self-Image Scale (FGSIS) score, from 7 (worst) to 28 (best)
Time frame: 6 months and 24 months
Sexual quality
Evaluate evolution of sexual quality of life with Operated Male-to-Female Sexual Function Index (OmtFSFI) score, from 18 (best) to 72 (worst)
Time frame: 6 months and 24 months
Post-operative issues
Epidemiologic census of post-operative issues
Time frame: Instantly, 6 months and 24 months
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Sep 2025, 24 months after the start.
Of 14 interventional studies with no phase under Transsexualism, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 36. This study's planned 24 months is close to that.
Transsexualism covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Limoges →